4385 related articles for article (PubMed ID: 19731816)
1. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
2. Current and future therapy in Alzheimer's disease.
van Marum RJ
Fundam Clin Pharmacol; 2008 Jun; 22(3):265-74. PubMed ID: 18485144
[TBL] [Abstract][Full Text] [Related]
3. [Alzheimer's disease: from brain lesions to new drugs].
Forette F; Hauw JJ
Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
[TBL] [Abstract][Full Text] [Related]
4. Amyloid inhibitors and Alzheimer's disease.
Xia W
Curr Opin Investig Drugs; 2003 Jan; 4(1):55-9. PubMed ID: 12625030
[TBL] [Abstract][Full Text] [Related]
5. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
Franke AG; Lieb K; Fellgiebel A
Fortschr Neurol Psychiatr; 2009 Jun; 77(6):326-33. PubMed ID: 19504422
[TBL] [Abstract][Full Text] [Related]
6. Progress in Alzheimer's disease drug discovery: an update.
Williams M
Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
[TBL] [Abstract][Full Text] [Related]
7. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
[No Abstract] [Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
9. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
10. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
11. Disease modifying therapy for AD?
Golde TE
J Neurochem; 2006 Nov; 99(3):689-707. PubMed ID: 17076654
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies.
Cummings JL
Rev Neurol Dis; 2007; 4(2):57-62. PubMed ID: 17609636
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
Abe K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer's disease: therapeutic perspectives].
Dubois B; De Souza L; Allali G; Kalafat M; Sarazin M
Bull Acad Natl Med; 2008 Feb; 192(2):333-42; discussion 343-4. PubMed ID: 18819687
[TBL] [Abstract][Full Text] [Related]
15. Dual action of memantine in Alzheimer disease: a hypothesis.
Wu TY; Chen CP
Taiwan J Obstet Gynecol; 2009 Sep; 48(3):273-7. PubMed ID: 19797019
[TBL] [Abstract][Full Text] [Related]
16. Investigational medications for treatment of patients with Alzheimer disease.
Potter PE
J Am Osteopath Assoc; 2010 Sep; 110(9 Suppl 8):S27-36. PubMed ID: 20926740
[TBL] [Abstract][Full Text] [Related]
17. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
Song MS; Rauw G; Baker GB; Kar S
Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
[TBL] [Abstract][Full Text] [Related]
18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
19. Disease-modifying therapies in Alzheimer's disease: how far have we come?
Hüll M; Berger M; Heneka M
Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Abeta production by NF-kappaB inhibitors.
Paris D; Patel N; Quadros A; Linan M; Bakshi P; Ait-Ghezala G; Mullan M
Neurosci Lett; 2007 Mar; 415(1):11-6. PubMed ID: 17223266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]